M&A Deal Summary

QPS Acquires Development Center - Center of Toxicology & Preclinical Sciences

On February 14, 2011, QPS acquired life science company Development Center - Center of Toxicology & Preclinical Sciences from Development Center for Biotechnology

Acquisition Highlights
  • This is QPS’s 2nd transaction in the Life Science sector.
  • This is QPS’s 1st transaction in Taiwan.

M&A Deal Summary

Date 2011-02-14
Target Development Center - Center of Toxicology & Preclinical Sciences
Sector Life Science
Buyer(s) QPS
Sellers(s) Development Center for Biotechnology
Deal Type Divestiture

Target

Development Center - Center of Toxicology & Preclinical Sciences

New Taipei City, Taiwan
Development Center - Center of Toxicology & Preclinical Sciences engages in nonclinical toxicity and safety testing, genetic toxicology, reproductive toxicology, immunotoxicity testing, biocompatibility testing, and DMPK studies.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

QPS

Newark, Delaware, United States

Category Company
Founded 1995
Sector Life Science
DESCRIPTION

QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide in the areas of Bioanalysis, Drug Metabolism and Pharmacokinetics, Toxicology, Translational Medicine, and Clinical Research. QPS was established in 1995 and is based in Newark, Delaware.


DEAL STATS #
Overall 4 of 7
Sector: Life Science M&A 2 of 4
Type: Divestiture M&A Deals 1 of 1
Country: Taiwan M&A 1 of 2
Year: 2011 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-01-26 Bioserve Clinical Research

Hyderabad, India

Bioserve Clinical Research (P) Ltd. is a regulatory class CRO, offering end-to-end services, primarily catering to the needs of the generic pharmaceutical industry.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-08 Qualitix Clinical Research Co.

Taipei, Taiwan

Qualitix Clinical Research Co., Ltd. is a Contract Research Organization and Site Management Organization offering high quality, cost effective research development services to assist clients in pharmaceutical, biotechnology and medical device industries engaged in new drug development and phase I-IV multinational clinical trials.

Buy -

Seller(S) 1

SELLER

Development Center for Biotechnology

New Taipei City, Taiwan

Category Company
Founded 1984
Sector Life Science
DESCRIPTION

The Development Center for Biotechnology (DCB) of Taiwan is a nonprofit organization based on government grants and private donations. DCB's mission is to accelerate the development of Taiwan's biotech-pharma industry, by accomplishing the main objectives of building infrastructures, developing key technologies, promoting cooperation and industrialization, and training talented workforces, in coordination with governmental, industrial, and academic institutions.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Taiwan M&A 1 of 1
Year: 2011 M&A 1 of 1